ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Vaccination"

  • 2016 American Transplant Congress

    A 5-Year Multicenter Evaluation of Seasonal Influenza Infection in Transplant Recipients.

    D. Kumar,1 E. Cordero,4 E. Blumberg,2 A. Limaye,5 M. Levi,7 L. Danziger-Isakov,9 J. Englund,8 S. Husain,1 F. Silveira,10 G. Reid,6 T. Sharma,3 A. Humar.1

    1UHN, Toronto, Canada; 2UPenn, Philadelphia; 3BCH, Boston; 4REIPI, Seville, Spain; 5UoWMC, Seattle; 6LUMC, Chicago; 7UCD, Denver; 8SCH, Seattle; 9CCHMC, Cincinnati; 10UPMC, Pittsburgh.

    Background:Seasonal influenza infection may cause significant morbidity and mortality in transplant patients. However, there are limited prospective data on clinical presentations and determinants of outcomes.…
  • 2015 American Transplant Congress

    Heterologous Immune Responses to Influenza Vaccine in Kidney Transplant Recipients

    D. Kumar,1 P. Campbell,2 K. Hoschler,3 A. Humar.1

    1Univ Health Network, Toronto, Canada; 2Univ of Alberta, Edmonton, Canada; 3Public Health England, London, United Kingdom.

    Background:Influenza vaccine is known to have suboptimal immunogenicity in transplant recipients. However, influenza vaccine may have the added benefit of inducing a cross-reactive immune response…
  • 2015 American Transplant Congress

    Assessing Pre-Vaccination Cytokine Levels to Predict Immunogenicity to Seasonal Trivalent Influenza Vaccine in Solid Organ Transplant Recipients

    M. Fernandez-Ruiz, A. Humar, S. Keshwani, S. Husain, D. Kumar.

    Multi-Organ Transplant Program, University Health Network, Toronto, Canada.

    Background: The immunogenicity of seasonal trivalent influenza vaccine (TIV) in solid organ transplant (SOT) recipients remains suboptimal. We hypothesized that analysis of pre-vaccination T- and…
  • 2015 American Transplant Congress

    Vaccine Responses in Combined Hematopoeitic Stem Cell-Kidney Transplant Recipients

    C. Feng,1 M. Ison,1 J. Galvin,1 S. Ildstad,2,3 D. Stare,1 J. Leventhal.1

    1Northwestern University, Chicago, IL; 2University of Louisville, Louisville, KY; 3Regenerex, LLC, Louisville, KY.

    Background: Vaccines remain one of the most effective methods of preventing infections following transplantation. Data suggests that vaccine responses are reduced in recipients of hematopoeitic…
  • 2015 American Transplant Congress

    Suboptimal Vaccination Coverage After Liver Transplantation: Opportunity for Improvement

    L. Danziger-Isakov, S. Blum, G. Paulsen, M. Lake, R. Rengering, M. Duncan, J. Zigmond, K. Campbell, J. Bucuvalas.

    Cincinnati Children's Hospital Medical Center, Cincinnati, OH.

    Elimination of vaccine-preventable disease after solid organ transplantation (SOT) has the potential to improve outcomes. We evaluated immunization rates and the impact of directed recommendations…
  • 2015 American Transplant Congress

    Boosting the Adaptive Immune Response Prevents the High Incidence of Herpes Zoster After Lung or Heart Transplantation

    N. van Besouw,1 S. Roest,2 J. Zuijderwijk,1 R. de Kuiper,1 J. van Weezel,3 A. van der Eijk,4 W. Weimar,1 P. Hal,3 O. Manintveld.2

    1Internal Medicine - Transplantation, Erasmus MC, Rotterdam, Netherlands; 2Cardiology, Erasmus MC, Rotterdam, Netherlands; 3Respiratory Medicine, Erasmus MC, Rotterdam, Netherlands; 4Viroscience, Erasmus MC, Rotterdam, Netherlands.

    Purpose Primary varicella zoster virus (VZV) infection causes varicella and lifelong latent infection in ganglia from which it may reactivate leading to herpes zoster (HZ).…
  • 2015 American Transplant Congress

    Vaccination to Prevent the High Herpes Zoster Incidence After Renal Transplantation

    M. Kho,1 W. Weimar,1 D. Boveé,1 M. Boer-Verschragen,1 A. van der Eijk,2 N. van Besouw.1

    1Internal Medicine - Nephrology and Transplantation, Erasmus Medical Center, Rotterdam, Netherlands; 2Viroscience, Erasmus Medical Center, Rotterdam, Netherlands.

    Introduction: Herpes zoster (HZ) is the clinical manifestation of varicella zoster virus (VZV) reactivation and occurs more frequently in people with a suppressed immune system.…
  • 2015 American Transplant Congress

    The Effect of Influenza Vaccination on Hospital Admission in Solid Organ Transplant Recipients

    J. Rago, M. Hurtik, S. Todd, A. Mehta, G. Lyon III.

    Emory University Hospital, Atlanta, GA.

    Purpose: The current study has two objectives. First, compare clinical outcomes between solid organ transplant (SOT) recipients who receive influenza vaccination and those who do…
  • 2015 American Transplant Congress

    CFZ533: Assessment of Immunomodulatory Activity Following Single Doses of a Novel Anti-CD40 mAb in Healthy Volunteers

    A. Slade,1 J. Doucet,2 P. Koo,1 P. Espie,2 J. Rush,2 C. Tomek,3 J. Klupp.2

    1Novartis Institute for Biomedical Research, East Hanover, NJ; 2Novartis Institute for Biomedical Research, Basel, Switzerland; 3Celerion, Inc, Lincoln, NE.

    Blocking the CD40-CD154 pathway has been shown to effectively prolong renal allograft survival in non-human primates. CFZ533 is a novel, fully human, Fc-silent, anti-CD40 monoclonal…
  • 2015 American Transplant Congress

    Vaccine-Induced 'Incognito' CD8+ T Cell Memory Can Disrupt Transplantation Tolerance

    M. Nelsen,1 K. Beard,2 R. Kedl,1 R. Gill.2

    1Dept of Immunology & Microbiology, Univ of Colorado, Aurora, CO; 2Dept of Surgery, Univ of Colorado, Aurora, CO.

    Transplant recipients harbor immunity to vaccines and pathogens (e.g. CMV, EBV). Pre-existing immunity can have significant antigen-specific ramifications, usually attributed to heterologous immunity, as pathogen-reactive…
  • « Previous Page
  • 1
  • …
  • 15
  • 16
  • 17
  • 18
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences